White House Signals a “Third Lane” for Full Spectrum CBD as Hemp Rules Tighten and Marijuana Rescheduling Lags

Cannabis attorney Tom Howard argues the key development is not that an executive order legalized full spectrum CBD for Medicare, but that the White House is simultaneously pushing marijuana to Schedule III and calling for access to appropriate full spectrum CBD even as Congress’s new hemp definition (Section 781) will likely push many full spectrum products back into “marijuana” via a strict total-THC, per-container cap effective November 12, 2026. He says the order does three things: urges DOJ to finish rescheduling, directs work with Congress to update hemp’s statutory definition, and instructs HHS/NIH to develop real-world-evidence research models for hemp-derived cannabinoids. With FDA guidance late and rescheduling unfinished, Howard predicts a future “middle lane” of regulated, evidence-backed, largely non-intoxicating cannabinoid therapeutics integrated into healthcare, distinct from both intoxicating hemp products and broader marijuana legalization.

00:00 Why This Matters
00:55 Two Legal Boxes
01:40 Executive Order Breakdown
02:58 New Hemp Definition Trap
04:25 A Third Regulatory Lane
05:41 Bills Deadlines FDA Drift
07:03 Rescheduling Is Not Legalization
09:05 Endgame Medical Framework
10:33 What We Still Dont Have
11:27 How Legalization Really Happens
12:58 Wrap Up And Outro

We dive deep into the latest cannabis news, discussing the ever-changing legal landscape and its impact on the industry. This week, we explore critical regulations and political news shaping the future, alongside significant market trends. Stay informed on the laws affecting cannabis businesses and consumers alike.